SCHEMBL55484

SCHEMBL55484

C[CH]CC(C)(C)CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18729631 0.79 TSHR (0.38)
SCHEMBL8076922 0.77 LMNA (0.33)
SCHEMBL56624 0.75
SCHEMBL27768258 0.74
SCHEMBL21238891 0.74
SCHEMBL1410793 0.74
SCHEMBL28800604 0.74
SCHEMBL11517981 0.74
SCHEMBL3292585 0.74
SCHEMBL55485 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1938260-B Alkylated PANA and DPA compositions CIBA SC HOLDING AG 2010-06-16 CN claimed
CN-1938260-A Alkylated pana and dpa compositions CIBA SC HOLDING AG (CH) 2007-03-28 CN claimed
CN-113444376-A Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element 日产化学工业株式会社 2021-09-28 CN disclosed
CN-111684325-A Cured liquid crystal layer, method for producing same, optical film, polarizing plate, and display device 日本瑞翁株式会社 2020-09-18 CN disclosed
EP-1753862-B1 METHODS FOR OBTAINING OPTICALLY ACTIVE EPOXIDES AND VICINAL DIOLS FROM MESO-EPOXIDES CSIR (ZA) 2015-11-18 EP disclosed
EP-2439236-B1 RUBBER COMPOSITION BRIDGESTONE CORP (JP) 2014-10-01 EP disclosed
EP-2420491-B1 3 , 5-SUBSTITUED PIPERIDINE COMPOUNDS AS RENIN INHIBITORS NOVARTIS AG (CH) 2013-07-03 EP disclosed
CN-102803372-A Rubber composition BRIDGESTONE CORP 2012-11-28 CN disclosed
US-20120136102-A1 RUBBER COMPOSITION BRIDGESTONE CORPORATION (JP) 2012-05-31 US disclosed
US-8129411-B2 Organic compounds NOVARTIS AG (CH) 2012-03-06 US disclosed
EP-2420491-A1 3 , 5-substitued piperidine compounds as renin inhibitors Novartis AG (CH) 2012-02-22 EP disclosed
EP-0153639-A2 Process for the preparation of cellular or compact polyurethane-polyurea mouldings having modified mould release properties, and internal mould release agents for the polyisocyanate-polyaddition process BASF Aktiengesellschaft (DE) 1985-09-04 EP disclosed
EP-0145999-A2 Thermosetting composition having a prolonged pot life at room temperature on the basis of compounds having reactive hydrogen atoms and polyisocyanates, process for their preparation and their use in the preparation of moulded articles BASF Aktiengesellschaft (DE) 1985-06-26 EP disclosed
US-4469653-A AS POLYMERIZATION CATALYSTS BASF AKTIENGESELLSCHAFT (DE) 1984-09-04 US disclosed
US-4440705-A FROM POLYETHER POLYOLS WITH TERMINAL HYDROXYETHYLENE GROUPS BASF AKTIENGESELLSCHAFT (DE) 1984-04-03 US disclosed
EP-0093334-A1 Process for the production of possibly cellular moulded articles from polyurea elastomers BASF Aktiengesellschaft (DE) 1983-11-09 EP disclosed
EP-0093335-A1 Process for the production of moulded bodies on the basis of polyurethane or polyurethane-polyurea elastomers with a particular light and weather resistance BASF Aktiengesellschaft (DE) 1983-11-09 EP disclosed
EP-0093336-A2 Method of preparing compact or cellular moulded bodies of polyurea-polyurethane elastomers BASF Aktiengesellschaft (DE) 1983-11-09 EP disclosed
EP-0069287-A1 Process for the manufacture of possibly cellular polyurethane elastomers BASF Aktiengesellschaft (DE) 1983-01-12 EP disclosed
EP-0069295-A1 Process for the manufacture of possibly cellular polyurethane or polyurethane-polyurea moulded articles BASF Aktiengesellschaft (DE) 1983-01-12 EP disclosed